- Home
- GENC vs HUMA Comparison
GENC vs HUMA Comparison
Compare GENC & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENC | HUMA |
|---|---|---|
| Founded | N/A | 2004 |
| Country | US | |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.4M | 182.6M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | GENC | HUMA |
|---|---|---|
| Price | $15.14 | $1.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $16.00 | $10.00 |
| AVG Volume (30 Days) | 25.3K | ★ 6.1M |
| Earning Date | 05-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.08 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $48,943,000.00 | N/A |
| Revenue This Year | $125,306.93 | N/A |
| Revenue Next Year | $3.54 | $731.05 |
| P/E Ratio | $66.43 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.80 | $0.88 |
| 52 Week High | $17.40 | $3.94 |
Technical Indicators
Market Signals| Indicator | GENC | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 58.35 | 53.53 |
| Support Level | $14.94 | $0.96 |
| Resistance Level | $16.00 | $1.16 |
| Average True Range (ATR) | 0.68 | 0.10 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 68.84 | 56.78 |
Price Performance
Historical ComparisonAbout GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.